BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/9/2023 11:18:42 AM | Browse: 334 | Download: 1178
 |
Received |
|
2023-06-08 06:01 |
|
Peer-Review Started |
|
2023-06-08 06:04 |
|
First Decision by Editorial Office Director |
|
2023-07-18 07:53 |
|
Return for Revision |
|
2023-07-18 07:53 |
|
Revised |
|
2023-07-22 11:12 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-08-09 03:09 |
|
Second Decision by Editor-in-Chief |
|
2023-08-13 09:43 |
|
Final Decision by Editorial Office Director |
|
2023-08-17 02:26 |
|
Articles in Press |
|
2023-08-17 02:26 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-09-19 02:06 |
|
Publish the Manuscript Online |
|
2023-10-09 11:18 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Indirect comparison of efficacy and safety of chiglitazar and thiazolidinedione in patients with type 2 diabetes: A meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Chu Lin, Zong-Lin Li, Xiao-Ling Cai, Sui-Yuan Hu, Fang Lv, Wen-Jia Yang and Li-Nong Ji |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Beijing Natural Science Foundation |
7202216 |
| National Natural Science Foundation of China |
81970698 |
| National Natural Science Foundation of China |
81970708 |
|
| Corresponding Author |
Li-Nong Ji, MD, Professor, Department of Endocrinology and Metabolism, Peking University People’s Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing 100044, China. jiln@bjmu.edu.cn |
| Key Words |
Chiglitazar; Thiazolidinedione; Glycemic control; β-cell function; Drug safety |
| Core Tip |
This is the first indirect meta-analysis comparing efficacy and safety of chiglitazar and thiazolidinediones (TZDs). In patients with type 2 diabetes, compared with TZDs, chiglitazar induced favorable glycemic and lipidemic control, preserved β-cell function, without increasing safety concerns. |
| Publish Date |
2023-10-09 11:18 |
| Citation |
Lin C, Li ZL, Cai XL, Hu SY, Lv F, Yang WJ, Ji LN. Indirect comparison of efficacy and safety of chiglitazar and thiazolidinedione in patients with type 2 diabetes: A meta-analysis. World J Diabetes 2023; 14(10): 1573-1584 |
| URL |
https://www.wjgnet.com/1948-9358/full/v14/i10/1573.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v14.i10.1573 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
